Riboscience

Riboscience is a clinical stage biotechnology company headquartered in Sunnyvale, California. As a small business with five employees, Riboscience focuses its efforts on developing innovative treatments for serious diseases. The company specializes in the research, development, and potential commercialization of drugs targeting proteins essential to the survival of infectious pathogens, tumor cells, and the anti-tumor immune response. Riboscience utilizes ribose and structure-guided design technologies to create drugs with high specificity, aiming to minimize off-target effects and improve patient outcomes. Riboscience's commitment to scientific rigor and innovation sets it apart in the field of biotechnology. By focusing on unique protein targets and employing cutting-edge technologies, the company strives to develop treatments that address unmet medical needs in infectious disease and cancer therapy. For more information about Riboscience, its research, and potential therapeutic candidates, please visit their website at riboscience.com.